Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4510-4513

  Leitch, Ian M ^a,b   Boura, Alan L A ^a   Botti, Chiara ^a   Read, Mark A ^a   Walters, William A W ^a   Smith, Roger ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Miravant Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; UROCORTIN; UROTENSIN I;

ADOLESCENT; ADULT; ARTERY PERFUSION; ARTICLE; BLOOD VESSEL TONE; FEMALE; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN TISSUE; PLACENTA CIRCULATION; PLACENTA FUNCTION; PLACENTA PERFUSION; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

EID: 0032452925     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.12.4510     Document Type: Article

References (22)

1. 1. Vaughan J, Donaldson C, Bittencourt J, et al. 1995 Urocortin, a mammalian neuropeptide related to fish urotensin 1 and to corticotropin-releasing factor. Nature. 378:287-292.
2. 2. Donaldson CJ, Sutton SW, Perrin MH, et al. 1996 Cloning and characterisation of human urocortin. Endocrinology. 137:2167-2170.
3. 3. Lederis K, Letter A, McMaster D, Moore G, Schlesinger D. 1982 Complete amino acid sequence of urotensin 1, a hypotensive and corticotropin-releasing peptide from Catostomus. Science. 218:162-164.
4. 4. Lederis K, Fryer J, Rivier J, et al. 1985 Neurohormones from fish tails. Part II: Actions of urotensin 1 in mammals and fishes. In: Greep RO, ed. Recent progress in hormone research. San Diego: Academic Press; vol 41:553-576.
5. 5. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB. 1996 Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci. 17:166-172.
6. 6. Vale W, Vaughan J, Perrin M. 1997 Corticotropin-releasing factor (CRF) family of ligands and their receptors. Endocrinologist. 7(Suppl 1):S3-S9.
7. 7. Dieterich KD, Lehnert H, De Souza EB. 1997 Corticotropin-releasing factor receptors: an overview. Exp Clin Endocrinol Diabetes. 105:65-82.
8. 8. Petraglia F, Giardino L, Coukos G, Calza L, Vale W, Genazzani AR. 1990 Corticotropin-releasing factor and parturition: plasma and amniotic fluid levels and placental binding sites. Obstet Gynecol. 75:784-789.
9. 9. Saeed BO, Weightman DR, Self CH. 1997 Characterization of corticotropin-releasing hormone binding sites in the human placenta. J Receptor Signal Transduction Res. 17:647-666.
10. 10. Clifton VL, Read MA, Leitch IM, Boura ALA, Robinson PJ, Smith, R. 1994 Corticotrophin-releasing hormone-induced vasodilation in the human fetal placental circulation. J Clin Endocrinol Metab. 79:666-669.
11. 11. Clifton VL, Read MA, Leitch IM, et al. 1995 Corticotrophin-releasing hormone-induced vasodilation in the human fetal placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab. 80:2888-2893.
12. 12. Petraglia F, Florio P, Gallo R, et al. 1996 Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab. 81:3807-3810.
13. 13. Boura ALA, Walters WAW, Read MA, Leitch IM. 1994 Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol. 21:737-748.
14. 14. Riley SC, Walton JC, Herlick JM, Challis JRG. 1991 The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab. 72:1001-1007.
15. 15. Roe C, Leitch IM, Boura ALA, Smith R. 1996 Nitric oxide regulation of corticotrophin-releasing hormone release from the human perfused placenta in vitro. J Clin Endocrinol Metab. 81:763-769.
16. 16. Leitch IM, Roe CM, Walters WAW, Smith R, Boura ALA. 1997 Effect of the L-arginine-nitric oxide pathway on human placental vascular tone and corticotropin-releasing hormone secretion. Hyperten Preg. 16:367-378.
17. 17. Theoharides TC, Boucher W, Singh L, Pang X. Urocortin is a potent inducer of skin mast cell activation and vasodilation: implications for stress-induced atopic diseases [Abstract OR18-1]. Proc of the 79th Annual Meet of The Endocrine Soc. 1997; 89.
18. 18. Kishimoto T, Pearse R, Lin C, Rosenfeld M. 1995 A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA. 92:2969-2973.
19. 19. Perrin MH, Donaldson CJ, Chen R, et al. 1995 Identification of a second CRF receptor gene and characterization of a cDNA expressed in the heart. Proc Natl Acad Sci USA. 92:2969-2973.
20. 20. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB, Stenzel-Poore MP. 1995 Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol. 9:637-645.
21. 21. Rohde E, Furket J, Fechner K, et al. 1996 Corticotropin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem Pharmacol. 52:829-833.
22. 22. Chalmers DT, Lovenberg TW, De Souza EB. 1995 Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci. 15:6340-6350.